CLOs on the Move

Family Healthcare Network

www.fhcn.org

 
Family HealthCare Network is a private nonprofit organization that operates 20 sites, 16 of which are federally qualified health centers located throughout Tulare and Kings Counties. Our mission is to provide quality health care to everyone in the communities we serve. With more than 160 medical and dental providers in our network, we provide access to a wide range of coordinated health services. FHCN also offers pharmacy services, free transportation, and extended evening and weekend hours. FHCN is recognized by the National Committee for Quality Assurance (NCQA) as a Level 3 Patient Centered Medical Home and is dually recognized by ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.fhcn.org
  • Family HealthCare Network
    Visalia, CA USA 93291
  • Phone: 877.960.3426

Executives

Name Title Contact Details

Similar Companies

Centralized Research Services

Centralized Research Services is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lifesource Upper Midwest Organ

LifeSource is the non-profit organization dedicated to saving lives through organ and tissue donation in the Upper Midwest. Our service area includes Minnesota, North Dakota, South Dakota and portions of western Wisconsin. As the bridge between donation

Allion Healthcare

Allion Healthcare, Inc. is a provider of specialty pharmacy and disease management services focused on Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) patients, as well as specialized biopharmaceutical medications and services

Southern Oregon Orthopedics Inc

The physicians of Southern Oregon Orthopedics, Inc. have been providing the residents of Southern Oregon and Northern California with high quality orthopedic care for the past 50 years. Our physicians are active staff members at Rogue Valley Medical

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.